Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 17th:
Pfizer (PFE - Free Report) : This company that manufactures and sells biopharmaceutical products worldwide carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.7% over the last 60 days.
Pfizer has a PEG ratio of 0.76 compared with 1.76 for the industry. The company possesses a Growth Score of B.
Macy's (M - Free Report) : This omnichannel retail organization carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.9% over the last 60 days.
Macy's has a PEG ratio of 0.45 compared with 0.57 for the industry. The company possesses a Growth Score of B.
Accenture (ACN - Free Report) : This consulting services provider carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.2% over the last 60 days.
Accenture has a PEG ratio of 0.94 compared with 1.71 for the industry. The company possesses a Growth Score of B.
See the full list of top ranked stocks here.
Learn more about the Growth score and how it is calculated here.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 17th:
Pfizer (PFE - Free Report) : This company that manufactures and sells biopharmaceutical products worldwide carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.7% over the last 60 days.
Pfizer has a PEG ratio of 0.76 compared with 1.76 for the industry. The company possesses a Growth Score of B.
Macy's (M - Free Report) : This omnichannel retail organization carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.9% over the last 60 days.
Macy's has a PEG ratio of 0.45 compared with 0.57 for the industry. The company possesses a Growth Score of B.
Accenture (ACN - Free Report) : This consulting services provider carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.2% over the last 60 days.
Accenture has a PEG ratio of 0.94 compared with 1.71 for the industry. The company possesses a Growth Score of B.
See the full list of top ranked stocks here.
Learn more about the Growth score and how it is calculated here.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ACN - FREE
Get the latest research report on PFE - FREE
Get the latest research report on M - FREE